microdosing
A new study has found that microdosing with LSD can lead to earlier bedtimes and longer sleep durations. Participants in the study, published in Translational Psychiatry, slept an average of 24 minutes longer on the night following a microdose. They also went to bed 25 minutes earlier than usual while waking up at their typical time. Lysergic acid diethylamide, commonly known as LSD, is a potent hallucinogenic drug that alters perception, mood, and various cognitive processes. It belongs to the class of drugs known as psychedelics. LSD was first synthesized in 1938 by Albert Hofmann and became...
PsyPost
A new study has found that microdosing with LSD can lead to earlier bedtimes and longer sleep durations. Participants in the study, published in Translational Psychiatry, slept an average of 24 minutes longer on the night following a microdose. They also went to bed 25 minutes earlier than usual while waking up at their typical time. Lysergic acid diethylamide, commonly known as LSD, is a potent hallucinogenic drug that alters perception, mood, and various cognitive processes. It belongs to the class of drugs known as psychedelics. LSD was first synthesized in 1938 by Albert Hofmann and became...
PsyPost (UK)
A new study has found that microdosing with LSD can lead to earlier bedtimes and longer sleep durations. Participants in the study, published in Translational Psychiatry, slept an average of 24 minutes longer on the night following a microdose. They also went to bed 25 minutes earlier than usual while waking up at their typical time. Lysergic acid diethylamide, commonly known as LSD, is a potent hallucinogenic drug that alters perception, mood, and various cognitive processes. It belongs to the class of drugs known as psychedelics. LSD was first synthesized in 1938 by Albert Hofmann and became...
PsyPost (CA)
A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning. ADHD is typically marked by inattention, hyp...
PsyPost (CA)
A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning. ADHD is typically marked by inattention, hyp...
PsyPost
A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning. ADHD is typically marked by inattention, hyp...
PsyPost (UK)
A recent study has shown that even very low doses of LSD can enhance the complexity of brain activity, a finding that might have significant implications for our understanding of consciousness and possibly for therapeutic applications. The study, published in the journal Neuropsychopharmacology, found that while substances like THC (tetrahydrocannabinol) and methamphetamine did not produce the same effect, LSD distinctly increased neural complexity and affected brain wave patterns associated with states of consciousness. Neural complexity is a concept that attempts to quantify the intricate pa...
PsyPost
A recent study has shown that even very low doses of LSD can enhance the complexity of brain activity, a finding that might have significant implications for our understanding of consciousness and possibly for therapeutic applications. The study, published in the journal Neuropsychopharmacology, found that while substances like THC (tetrahydrocannabinol) and methamphetamine did not produce the same effect, LSD distinctly increased neural complexity and affected brain wave patterns associated with states of consciousness. Neural complexity is a concept that attempts to quantify the intricate pa...
PsyPost (CA)
A recent study has shown that even very low doses of LSD can enhance the complexity of brain activity, a finding that might have significant implications for our understanding of consciousness and possibly for therapeutic applications. The study, published in the journal Neuropsychopharmacology, found that while substances like THC (tetrahydrocannabinol) and methamphetamine did not produce the same effect, LSD distinctly increased neural complexity and affected brain wave patterns associated with states of consciousness. Neural complexity is a concept that attempts to quantify the intricate pa...
PsyPost (UK)
In a new study from the University of Southern Denmark, researchers have shed light on the effects of microdosing psilocybin, the active component in psychedelic mushrooms, in rats. The study offers preliminary evidence that small, regular doses of psilocybin could potentially offer therapeutic benefits, particularly in reducing stress-induced anhedonia (the inability to feel pleasure) and compulsive behaviors, without inducing significant anxiety or schizophrenic-like symptoms. The findings have been published in Molecular Psychiatry. Psilocybin, long known for its psychedelic effects, has re...
PsyPost
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら